Product NDC 63323-0349

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 63323-0349 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: Imipenem and Cilastatin Sodium.
  • Primary dosage form: Injection.
  • Common strength: 250 mg / 20mL; 250 mg / 20mL.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Fresenius Kabi USA, LLC.
  • Dosage forms shown: Injection.
  • Package quantities: 25 Vial, Single-Dose.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
Imipenem and Cilastatin Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL63323-0349-25250 mg / 20mL; 250 mg / 20mLInjection25 Vial, Single-Dose
Imipenem and Cilastatin Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL63323-0349-93250 mg / 20mL; 250 mg / 20mLInjection25 Vial, Single-Dose
Imipenem and Cilastatin Sodium 250 mg / 20mL; 250 mg / 20mL Injection 20 mL63323-0349-94250 mg / 20mL; 250 mg / 20mLInjection25 Vial, Single-Dose

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.